Calico Life Sciences Announces First Participant Dosed in Phase …
https://www.prnewswire.com/news-releases/calico-life-sciences-announces-first-participant-dosed-in-phase-1b-clinical-study-evaluating-abbv-cls-7262-for-the-treatment-of-vanishing-white-matter-disease-301807584.html
WEBApr 26, 2023 · SOUTH SAN FRANCISCO, Calif., April 26, 2023 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and healthspan, and founded by Alphabet ...
DA: 95 PA: 54 MOZ Rank: 4